Idexx Laboratories (IDXX) Capital Expenditures (2009 - 2026)

Idexx Laboratories (IDXX) has reported Capital Expenditures for 18 consecutive years, with $8.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Capital Expenditures fell 72.44% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $102.9 million (down 24.19% YoY), while the FY2025 annual figure was $124.7 million, up 3.1% from the prior year.
• Capital Expenditures came in at $8.3 million for Q1 2026 at Idexx Laboratories, down from $117.9 million in the prior quarter.
• The five-year high for Capital Expenditures was $117.9 million in Q4 2025, with the low at -$57.4 million in Q3 2025.
• Average Capital Expenditures over 5 years is $31.5 million, with a median of $30.0 million recorded in 2025.
• Across the five-year window, Capital Expenditures jumped 8166.27% in 2023 and plunged 168.81% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $49.2 million in 2022, then slumped by 33.87% to $32.6 million in 2023, then fell by 10.14% to $29.3 million in 2024, then jumped by 303.0% to $117.9 million in 2025, then tumbled by 92.98% to $8.3 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $8.3 million, $117.9 million, and -$57.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.